ScholarWorks@Korea University: Kim, Kyung Im

Detailed Information

Kim, Kyung Im (김경임)

Graduate School (Department of Pharmacy)

Research Area

Tel 044-860-1624
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

South Korea:3||Network metaanalysis:3||Attitude:3||Atopic dermatitis:2||medication management:2||knowledge:2||qualitative study:2||medication use:2||trend:1||pharmacist:1||pharmaceutical care:1||public health:1||Ischemic event:1||Secondary prevention:1||System:1||education:1||adolescents:1||Inpatient:1||Hematopoietic stem cell transplantation:1||Highdose chemotherapy:1||Validation:1||Phanerochaete chrysosporium:1||2Arylindoles:1||older adults:1||drugdrug interactions:1||semiconductor:1||Health knowledge:1||misinformation:1||Certification logo:1||anemia of chronic disease:1||pediatric:1||Glucagonlike peptide1 receptor agonist:1||cutaneous:1||Flowmediated dilation:1||drug safety:1||elderly:1||primary prevention:1||busulfan:1||NONMEM:1||potentially inappropriate medications:1||health:1||Advertisement:1||anemia:1||cardiovascular disease:1||Nonalcoholic fatty liver disease:1||Omega3:1||Type 2 diabetes:1||cholesterols:1||geriatric:1||glutathione Stransferase:1||venoocclusive disease:1||Statin:1||needs:1||의약품 안전사용 지식:1||의약품 안전사용 태도:1||Drugrelated problem:1||Estimation methods:1||chronic kidney disease:1||microRNA:1||mineral bone disorder:1||Glutamate carboxypeptidase II:1||Xray crystal structure:1||2(4hydroxybiphenyl3yl)1Hindoles:1||workplace health promotion:1||homing:1||bidirectional encoder representations from transformers (BERT):1||Women:1||eczema:1||stroke:1||Examination:1||Fatty Acids:1||adverse event reporting systems:1||empagliflozin:1||fish oil:1||network metaanalysis:1||triglycerides:1||pharmacokinetics:1||Specialist:1||의약품 안전사용 행동:1||교육요구도:1||Network analysis:1||docetaxel:1||Carborane:1||emergency department:1||drug utilization review:1||chronic diseases:1||Aged:1||Selfmedication:1||workplace:1||Organic disposable sanitary pads:1||Label:1||Innovative CBT item types:1||Licensure:1||Thiazolidinediones:1||Metaanalysis:1||Epidemiology:1||tyrosine kinase inhibitors:1||adverse events:1||future:1||economic outcome:1||nursing home:1||cardiovascular:1||statin:1||genetic polymorphisms:1||중고등학생:1||Firstorder conditional estimation with interaction:1||uremia:1||Core/shell nanoparticles:1||Doxorubicin:1||Solutol:1||cancer therapy:1||And practice:1||chronic myeloid leukemia:1||Glucoselowering agent:1||krill oil:1||systematic review:1||interprofessional:1||Effectiveness:1||Older people:1||Pharmacist:1||attitudes:1||Few subjects:1||Radiotherapy:1||Gold nanoparticles:1||Pluronic F68:1||amlodipine:1||dyslipidemia:1||memory CD8 T cells:1||neural cadherin:1||Health education:1||COVID19:1||garlic:1||Twitter:1||Safety:1||myocardial ischemia:1||practice:1||Computerbased test:1||Nonalcoholic steatohepatitis:1||Janus kinase inhibitors:1||Cohort study:1||Comorbidity:1||cardiovascular events:1||dipeptidylpeptidase IV inhibitors:1||safety management:1||forecasting:1||older people:1||rational pharmacotherapy:1||Certified:1||practices:1||Hematologic malignancy:1||Combination therapy:1||QLQHDC29:1||multilayer nanoparticles:1||metabolomics:1||pharmaceuticals:1||diabetes:1||homeostasis:1||employees:1||inflammation:1||Carotid IntimaMedia Thickness:1||Coronary Disease:1||Diagnostic Techniques:1||rheumatoid arthritis:1||Pulse wave velocity:1||Biologics:1||dapagliflozin:1||retrospective study:1||longterm care facility:1||Oncology:1||Markov chain Monte Carlo Bayesian:1||Quality of life:1||indole cyclization:1||hypertension:1||Overthecounter drugs:1||onsite clinic:1||asthma:1||Health Personnel:1||Cardiovascular:1||online patient reviews:1||potential adverse events:1||Type 2 diabetes mellitus:1||metaanalysis:1||Arterial stiffness:1||Endothelial function:1||Asthma:1||Efficacy:1||Inadequately controlled:1||sodiumglucose transporter 2 inhibitors:1||

RSS_1.0 RSS_2.0 ATOM_1.0

145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE